Wells Fargo & Company Eyenovia, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Eyenovia, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 5,946 shares of EYEN stock, worth $2,973. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,946
Previous 15,354
61.27%
Holding current value
$2,973
Previous $15,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding EYEN
# of Institutions
62Shares Held
11.8MCall Options Held
32.8KPut Options Held
7K-
Armistice Capital, LLC New York, NY6.06MShares$3.03 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$940,6450.0% of portfolio
-
Lasry Marc New York, NY548KShares$273,9030.33% of portfolio
-
Geode Capital Management, LLC Boston, MA409KShares$204,2610.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny393KShares$196,5860.0% of portfolio
About EYENOVIA, INC.
- Ticker EYEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,212,900
- Market Cap $17.1M
- Description
- Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...